159 related articles for article (PubMed ID: 22958407)
1. Systemic inflammation in COPD in relation to smoking status.
Serapinas D; Narbekovas A; Juskevicius J; Sakalauskas R
Multidiscip Respir Med; 2011 Aug; 6(4):214-9. PubMed ID: 22958407
[TBL] [Abstract][Full Text] [Related]
2. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
3. Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population.
Janciauskiene S; DeLuca DS; Barrecheguren M; Welte T; Miravitlles M; ;
Arch Bronconeumol (Engl Ed); 2020 Feb; 56(2):76-83. PubMed ID: 31153743
[TBL] [Abstract][Full Text] [Related]
4. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients.
Tanni SE; Pelegrino NR; Angeleli AY; Correa C; Godoy I
J Inflamm (Lond); 2010 Jun; 7():29. PubMed ID: 20534161
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
Caram LMO; Ferrari R; Nogueira DL; Oliveira M; Francisqueti FV; Tanni SE; Corrêa CR; Godoy I
Int J Chron Obstruct Pulmon Dis; 2017; 12():2015-2021. PubMed ID: 28744116
[TBL] [Abstract][Full Text] [Related]
6. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
7. [Systemic inflammatory profile of smokers with and without COPD].
Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers in chronic obstructive pulmonary disease patients with different α1 antitrypsin genotypes.
Serapinas D; Sitkauskiene B; Sakalauskas R
Arch Med Sci; 2012 Dec; 8(6):1053-8. PubMed ID: 23319981
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD).
Andreeva E; Pokhasnikova M; Lebedev A; Moiseeva I; Kozlov A; Kuznetsova O; Degryse JM
J Thorac Dis; 2021 Aug; 13(8):4812-4829. PubMed ID: 34527321
[TBL] [Abstract][Full Text] [Related]
10. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
11. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
13. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
[TBL] [Abstract][Full Text] [Related]
14. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking and inflammatory indices in coronary artery disease.
Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z
Int J Cardiol; 2004 Feb; 93(2-3):169-74. PubMed ID: 14975543
[TBL] [Abstract][Full Text] [Related]
16. Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers.
Wozniak K; Sleszycka J; Safianowska A; Wiechno W; Domagala-Kulawik J
Arch Med Sci; 2012 Jul; 8(3):477-83. PubMed ID: 22852003
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein in patients with COPD, control smokers and non-smokers.
Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha as a marker of systemic and local inflammation in "healthy" smokers.
Diez-Pina JM; Fernandez-Aceñero MJ; Llorente-Alonso MJ; Diaz-Lobato S; Mayoralas S; Florez A
Int J Gen Med; 2009 Jul; 2():9-14. PubMed ID: 20360881
[TBL] [Abstract][Full Text] [Related]
19. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
20. Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.
Fisk M; Cheriyan J; Mohan D; McEniery CM; Forman J; Cockcroft JR; Rudd JHF; Tal-Singer R; Hopkinson NS; Polkey MI; Wilkinson IB
Respir Res; 2018 May; 19(1):100. PubMed ID: 29793484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
